By Justin Petrone

In a year when the word "sequencing" was on everyone's lips, microarray-based applications advanced steadily into routine clinical use.

During 2010, arrays became the standard of care for detecting constitutional abnormalities and researchers prepared to set guidelines for using arrays in clinical cancer cytogenetics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.